Medical supplies giant Medline said it was targeting an up to $55.3 billion valuation in its hotly anticipated U.S. initial public offering that is expected to be 2025’s biggest IPO. The Northfield, Illinois-based company is seeking to raise up to $5.37 billion by offering 179 million shares priced between $26 and $30 apiece. Medline’s blockbuster share sale is poised to be one of the year’s marquee listings, serving as a key gauge of investor sentiment as markets head into 2026. “The reception to Medline’s IPO will be crucial as it’s set to re-test the market for IPOs in sectors other than crypto, AI and fintech, which thus far has been really strong,” IPOX CEO Josef Schuster said.
Read the full article: Medical Supply Firm Medline Targets $55B Valuation in Blockbuster IPO //
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/medical-supply-firm-medline-aims-raise-54-billion-us-ipo-2025-12-08/